Proteoglycans in atherosclerosis and restenosis: Key roles for versican

Circulation Research

Volumn 94, Issue 9, 2004, Pages 1158-1167

  Wight, Thomas N ^a   Merrilees, Mervyn J ^b  

^a HOPE HEART INSTITUTE   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Atherosclerosis; Extracellular matrix; Proteoglycans; Smooth muscle cells; Versican

Indexed keywords

CYTOKINE; ENZYME; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HYALURONIC ACID; LIPOPROTEIN; PROTEOGLYCAN; VERSICAN;

ARTERY MUSCLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; ELASTIC FIBER; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLYCOPROTEIN SYNTHESIS; HUMAN; INFLAMMATION; LIPID STORAGE; MOLECULAR INTERACTION; NECROSIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; THROMBOSIS; THROMBUS; VASCULAR DISEASE; VISCOELASTICITY;

ANEURYSM; ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; LECTINS, C-TYPE; LIPOPROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; THROMBOSIS; VERSICANS;

EID: 2442681602     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000126921.29919.51     Document Type: Review

References (136)

1. Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 1994;14:213-225.
2. Wight T. The vascular extracellular matrix. In: Fuster V, Topol E, Nabel E, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott Williams and Wilkins. In press.
3. Järveläinen H, Wight T. Vascular proteoglycans. In: Garg H, Roughly P, Hales P, eds. Proteoglycans in Lung Disease. New York, NY: Marcel Dekker, 2002:291-321.
4. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem. 2002;277:4593-4596.
5. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989;8:2975-2981.
6. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem. 1995;270:958-965.
7. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002;14:617-623.
8. Naso MF, Zimmermann DR, Iozzo RV. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem. 1994;269:32999-33008.
9. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991;266:17640-17647.
10. 0. Atherosclerosis. 2001;154:367-376.
11. Merrilees MJ, Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis. 2001;12:7-16.
12. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J. 1990;11(suppl. E):3-19.
13. Radhakrishnamurthy B, Jeansonne N, Tracy RE, Berenson GS. A monoclonal antibody that recognizes hyaluronic acid binding region of aorta proteoglycans. Atherosclerosis. 1993;98:179-192.
14. Levesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis. 1994;105:51-62.
15. Binette F, Cravens J, Kahoussi B, Haudenschild DR, Goetinck PF. Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J Biol Chem. 1994;269:19116-19122.
16. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58:255-315.
17. Comper WD, Zamparo O. Hydrodynamic properties of connective-tissue polysaccharides. Biochem J. 1990;269:561-564.
18. Oegema TR, Hascall VC, Eisenstein R. Characterization of bovine aorta proteoglycan extracted with guanidine hydrochloride in the presence of protease inhibitors. J Biol Chem. 1979;254:1312-1318.
19. Kapoor R, Phelps CF, Wight TN. Physical properties of chondroitin sulphate/dermatan sulphate proteoglycans from bovine aorta. Biochem J. 1986;240:575-583.
20. Salisbury BGJ, Wagner WD. Isolation and preliminary characterization of proteoglycans dissociatively extracted form human aorta. J Biol Chem. 1981;256:8050-8057.
21. Wight TN, Hascall VC. Proteoglycans in primate arteries, III: characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture. J Cell Biol. 1983;96:167-176.
22. Chang Y, Yanagishita M, Hascall VC, Wight TN. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem. 1983;258:5679-5688.
23. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem. 2001;276:13372-13378.
24. Somerville RP, Longpre JM, Jungers KA, Engle JM, Ross M, Evanko S, Wight TN, Leduc R, Apte SS. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem. 2003;278:9503-9513.
25. Halpert I, Sires U, Potter-Perigo S, Wight TN, Shapiro DS, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localized to areas of versican deposits. Proc Natl Acad Sci U S A. 1996;93:9748-9753.
26. Kenagy RD, Fischer JW, Davies MG, Berceli SA, Hawkins SM, Wight TN, Clowes AW. Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol. 2002;22:400-404.
27. Gutierrez P, O'Brien KD, Ferguson M, Nikkari ST, Alpers CE, Wight TN. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc Pathol. 1997;6: 271-278.
28. Lin H, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM. Biglycan, decorin and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J Heart Lung Transplant. 1996; 15:1233-1247.
29. Lin H, Ignatescu M, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM. Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: geographic relationship to vessel wall proteoglycans. J Heart Lung Transplant. 1996;15:1223-1232.
30. Evanko S, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics and the proximity of PDGF and TGF-β1. Am J Pathol. 1998;152:533-546.
31. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A. A comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: co-localization of biglycan with apolipoproteins. Circulation. 1998;98:519-527.
32. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 2002;22:1642-1648.
33. Luttun A, Lupu F, Storkebaum E, Hoylaerts MF, Moons L, Crawley J, Bono F, Poole AR, Tipping P, Herbert JM, Collen D, Carmeliet P. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2002;22:499-505.
34. Geary RL, Wong JM, Rossini A, Schwartz SM, Adams LD. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2002;22:2010-2016.
35. Wagner WD, Salisbury GJ, Rowe HA. A proposed structure of chondroitin 6-sulfate proteoglycan of human normal and adjacent atherosclerotic plaque. Arteriosclerosis. 1986;6:407-417.
36. Dalferes ER Jr, Radhakrishnamurthy B, Ruiz HA, Berenson GS. Composition of proteoglycans from human atherosclerotic lesions. Exp Mol Pathol. 1987;47:363-376.
37. Cherchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, Tira ME, De Luca G. Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix. 1990;10:362-372.
38. Coinu R, Cherchi G, Formato M, Demuro P, De Luca G. LDL interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement. Haematologica. 1993;78:270-276.
39. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561.
40. Srinivasan SR, Lopez A, Radhakrishnamurthy B, Berenson GS. Complexing of serum pre-β and β-lipoproteins and acid mucopolysaccharides. Atherosclerosis. 1970;12:321-334.
41. Berenson GS, Radhakrishnamurthy B, Dalferes ER Jr, Srinivasan SR. Carbohydrate macromolecules and atherosclerosis. Hum Pathol. 1971; 2:57-79.
42. Hollander W. Unified concept on the role of acid mucopolysaccharides and connective tissue proteins in the accumulation of lipids, lipoproteins, and calcium in the atherosclerotic plaque. Exp Mol Pathol. 1976;25:106-120.
43. Camejo G, Lalaguna F, Lopez F, Starosta R. Characterization and properties of a lipoprotein-complexing proteoglycan from human aorta. Atherosclerosis. 1980;35:307-320.
44. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem. 1981;256:8234-8241.
45. Shi Y, Niculescu R, Wang D, Ormont M, Magno M, San Antonio JD, Williams KJ, Zalewski A. Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vasc Res. 2000;37:399-407.
46. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG, Ormont ML, Mannion JD, Zalewski A. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation. 2001;103:2408-2413.
47. Srinivasan SR, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS, Dolan P. Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesions. Biochim Biophys Acta. 1975;388:58-70.
48. Srinivasan SR, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson GS. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. Biochim Biophys Acta. 1989;1006:159-166.
49. Vijayagopal P, Figueroa JE, Fontenot JD, Glancy DL. Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques. Atherosclerosis. 1996; 127:195-203.
50. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis. 1996;124:261-271.
51. Srinivasan SR, Xu JH, Vijayagopal P, Radhakrishnamurthy B, Berenson GS. Injury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding property. Biochim Biophys Acta. 1993;1168:158-166.
52. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993;268:14131-14137.
53. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem. 2000;275:4766-4773.
54. Little PJ, Tannock L, Olin KL, Chait A, Wight TN. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol. 2002;22:55-60.
55. Olsson U, Bondjers G, Camejo G. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins. Diabetes. 1999;48:616-622.
56. Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL. Identification of a principal proteoglycan binding site in LDL: a single point mutation in apo B-100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest. 1998;101:2658-2664.
57. Olin KL, Potter-Perigo S, Barrett PH, Wight TN, Chait A. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem. 1999;274:34629-34636.
58. Cardoso LEM, Mourão PAS. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb. 1994;14: 115-124.
59. Sambandam T, Baker JR, Christner JE, Ekborg SL. Specificity of the low density lipoprotein-glycosaminoglycan interaction. Arterioscler Thromb. 1991;11:561-568.
60. Kunjathoor VV, Chiu DS, O'Brien KD, LeBoeuf RC. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2002;22:462-468.
61. Stefanovich V, Akiyama K. Comparative studies of aortic acid mucopolysaccharides in fifteen species. Comp Biochem Physiol. 1970;34: 125-130.
62. Gardais A, Picard J, Hermelin B. Glycosaminoglycan (GAG) distribution in aortic wall from five species. Comp Biochem Physiol B. 1973;44:507-515.
63. Flood C, Gustafsson M, Richardson PE, Harvey SC, Segrest JP, Boren J. Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem. 2002;277:32228-32233.
64. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750-754.
65. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb. 1992;12: 569-583.
66. 2 in vascular disease. Circ Res. 2001;89:298-304.
67. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apoB lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 1998;139:205-222.
68. Vijayagopal P. Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages. Biochem J. 1994;301:675-681.
69. Ismail NA, Alavi MZ, Moore S. Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. Atherosclerosis. 1994;105:79-87.
70. Llorente-Cortes V, Otero-Vinas M, Hurt-Camejo E, Martinez-Gonzalez J, Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol. 2002;22:387-393.
71. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
72. de la Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem. 1999;274:30747-30755.
73. Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem. 2000;275: 35448-35456.
74. de la Motte C, Hascall V, Drazba J, Strong S. Poly I:C induces mononuclear leukocyte-adhesive hyaluronan structures on colon smooth muscle cells: IαI and versican facilitate adhesion. In: Kennedy JF, Phillips GO, Williams PA, Hascall VC, eds. Hyaluronan. Volume I. Chemical, Biochemical and Biological Aspects. Cambridge, UK: Woodhead Publishing Limited; 2002:381-388.
75. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-α-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003;163:121-133.
76. Kawashima H, Li YF, Watanabe N, Hirose J, Hirose M, Miyasaka M. Identification and characterization of ligands for L-selectin in the kidney, I: versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin. Int Immunol. 1999;11:393-405.
77. Kawashima H, Atarashi K, Hirose M, Hirose J, Yamada S, Sugahara K, Miyasaka M. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem. 2002;277:12921-12930.
78. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J Biol Chem. 2001;276:5228-5234.
79. Hurt-Camejo E, Rosengren B, Sartipy P, Elfsberg K, Camejo G, Svensson L. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-γ and some of its biological effects on human vascular smooth muscle cells. J Biol Chem. 1999;274: 18957-18964.
80. Mazzucato M, Cozzi MR, Pradella P, Perissinotto D, Malmstrom A, Morgelin M, Spessotto P, Colombatti A, De Marco L, Perris R. Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. FASEB J. 2002;16: 1903-1916.
81. Koshiishi I, Shizari M, Underhill CB. CD44 can mediate the adhesion of platelets to hyaluronan. Blood. 1994;84:390-396.
82. McGee M, Wagner WD. Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:1921-1927.
83. Ernst CB. Abdominal aortic aneurysm. N Engl J Med. 1993;328: 1167-1172.
84. Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost. 2001;86:324-333.
85. Lindholt JS, Jorgensen B, Fasting H, Henneberg EW. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg. 2001;34:611-615.
86. Burke AP, Jarvelainen H, Kolodgie FD, Goel A, Wight TN, Virmani R. Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol. 2004; 17:482-488.
87. Melrose J, Whitelock J, Xu Q, Ghosh P. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells. J Vasc Surg. 1998;28:676-686.
88. Guo D, Hasham S, Kuang SQ, Vaughan CJ, Boerwinkle E, Chen H, Abuelo D, Dietz HC, Basson CT, Shete SS, Milewicz DM. Familial thoracic aortic aneurysms and dissections; genetic heterogeneity with a major locus mapping to 5q13-14. Circulation. 2001;103:2461-2468.
89. Iozzo RV, Naso MF, Cannizzaro LA, Wasmuth JJ, McPherson JD. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics. 1992;14:845-851.
90. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
91. Nikkari ST, Järveläinen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
92. 1 antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries. J Vasc Res. 2000;37:50-60.
93. Geary RL, Nikkari ST, Wagner WD, Williams JK, Adams MR, Dean RH. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 1998;27:96-106.
94. Finn AV, Gold HK, Tang A, Weber DK, Wight TN, Clermont A, Virmani R, Kolodgie FD. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res. 2002;39:414-425.
95. Matsuura R, Isaka N, Imanaka-Yoshida K, Yoshida T, Sakakura T, Nakano T. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. J Pathol. 1996;190:311-316.
96. Wight TN, Lara S, Reissen R, LeBaron R, Isner J. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol. 1997;151:963-973.
97. Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol. 2002;40:2072-2081.
98. Riessen R, Wight TN, Pastore C, Henley C, Isner JM. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 1996;93: 1141-1147.
99. Travis JA, Hughes MG, Wong JM, Wagner WD, Geary RL. Hyaluronan enhances contraction of collagen by smooth muscle cells and adventitial fibroblasts: role of CD44 and implications for constrictive remodeling. Circ Res. 2001;88:77-83.
100. Asundi V, Cowan K, Matzura D, Wagner W, Dreher KL. Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells. Eur J Cell Biol. 1990;52:98-104.
101. Schönherr E, Kinsella MG, Wight TN. Genistein selectively inhibits platelet-derived growth factor stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys. 1997;339: 353-361.
102. Lemire JM, Potter-Perigo S, Hall KL, Wight TN, Schwartz SM. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression. Arterioscler Thromb Vasc Biol. 1996;16:821-829.
103. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1630-1639.
104. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1004-1013.
105. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys. 2001;394:29-38.
106. Lee RT, Yamamoto C, Feng Y, Potter-Perigo S, Briggs WH, Landschulz KT, Turi TG, Thompson JF, Libby P, Wight TN. Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem. 2001;276: 13847-13851.
107. Morita H, Takeuchi T, Suzuki S, Maeda K, Yamada K, Eguchi G, Kimata K. Aortic endothelial cells synthesize a large chondroitin sulfate proteoglycan capable of binding to hyaluronate. Biochem J. 1990;265: 61-68.
108. Kinsella MG, Tsoi CK, Järveläinen HT, Wight TN. Selective expression and processing of biglycan during migration of bovine aortic endothelial cells: the role of endogenous basic fibroblast growth factor. J Biol Chem. 1997;272:318-325.
109. 1 in cultured bovine aortic endothelial cells. J Blol Chem. 2000;275:1463-1470.
110. Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, Morgelin M, Mucignat MT, Colombatti A, Perris R. Distribution of PG-M/ versican variants; in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem. 2002;277:47626-47635.
111. Schönherr E, Järveläinen HT, Kinsella MG, Sandell LJ, Wight TN. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb. 1993;13:1026-1036.
112. Shimizu-Hirota R, Sasamura H, Mifune M, Nakaya H, Kuroda M, Hayashi M, Saruta T. Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors. J Am Soc Nephrol. 2001;12: 2609-2615.
113. Potter-Perigo S, Baker C, Tsoi C, Braun K, Isenhath S, Altman G, Altman L, Wight T. Regulation of proteoglycan synthesis by leukotriene D4 and EGF in bronchial smooth muscle cells. Am J Respir Cell Mol Biol. 2004;30:101-108.
114. Edwards IJ, Wagner WD, Owens RT. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am J Pathol. 1990;136:609-621.
115. Ostberg CO, Zhu P, Wight TN, Qwarnstrom EE. Fibronectin attachment is permissive for IL-1 mediated gene regulation. FEBS Lett. 1995;367: 93-97.
116. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1996;97:596-603 [published erratum in J Clin Invest. 1996;98:877].
117. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1996;97:596-603 [published erratum in J Clin Invest. 1996;98:877].
118. Ye L, Mora R, Akhayani N, Haudenschild CC, Liau G. Growth factor and cytokine-regulated hyaluronan-binding protein TSG-6 is localized to the injury-induced rat neointima and confers enhanced growth in vascular smooth muscle cells. Circ Res. 1997;81:289-296.
119. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
120. Wu Y, Zhang Y, Cao L, Chen L, Lee V, Zheng PS, Kiani C, Adams ME, Ang LC, Paiwand F, Yang BB. Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem. 2001;276:14178-14186.
121. Zhang Y, Cao L, Yang BL, Yang BB. The G3 domain of versican enhances cell proliferation via epidermal growth factor-like motifs. J Biol Chem. 1998;273:21342-21351.
122. Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem. 1989;264:8012-8018.
123. Takagi H, Asano Y, Yamakawa N, Matsumoto I, Kimata K. Annexin 6 is a putative cell surface receptor for chondroitin sulfate chains. J Cell Sci. 2002;115:3309-3318.
124. Lemire JM, Merrilees MJ, Braun KR, Wight TN. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol. 2002;190:38-45.
125. Clark RAF, Henson PM. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press; 1988.
126. Clark RAF, Quinn JH, Winn HJ, Lanigan JM, Dellepella P, Colvin RB. Fibronectin is produced by blood vessels in response to injury. J Exp Med. 1982;156:646-651.
127. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393:276-280.
128. Brooke BS, Karnik SK, Li DY. Extracellular matrix in vascular morphogenesis and disease: structure versus signal. Trends Cell Biol. 2003; 13:51-56.
129. Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, Keating MT, Li DY. A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2003;130:411-423.
130. Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through elastin receptor facilitate proliferation and motility of arterial smooth muscle cells. J Biol Chem. 2002;277:44854-44863.
131. Hinek A, Mechan RP, Keeley F, Rabinovitch M. Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest. 1991;88:2083-2094.
132. Merrilees MJ, Lemire JM, Fischer JW, Kinsella MG, Braun KR, Clowes AW, Wight TN. Retrovirally mediated overexpression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res. 2002;90:481-487.
133. Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 1994;144:1068-1081.
134. Faris B, Tan OT, Toselli P, Franzblau C. Long-term neonatal rat aortic smooth muscle cell cultures: a model for the tunica media of a blood vessel. Matrix. 1992;12:185-188.
135. Hinek A, Braun KR, Liu K, Wang Y, Wight T. Retrovirally mediated overexpression of versican V3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol. 2004;164: 119-131.
136. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. The Cspg2 gene, disrupted in the HDF mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol. 1998; 202:56-66.